Soleno Therapeutics (SLNO) Current Leases (2019 - 2026)
Soleno Therapeutics (SLNO) reported Current Leases of $1.2 million for Q1 2026, up 93.83% year-over-year from $600000.0 in Q1 2025, and up 60.19% quarter-over-quarter from $726000.0 in Q4 2025.
Soleno Therapeutics (SLNO) Current Leases (2019 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 8 years of Current Leases data on file, last reported at $1.2 million in Q1 2026.
- Current Leases for Q1 2026 came in at $1.2 million, up 93.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 93.83% YoY), and the FY2025 annual result was $726000.0, up 45.2% from the prior year.
- Current Leases rose to $1.2 million in Q1 2026 per SLNO's latest filing, from $726000.0 in the prior quarter.
- Over five years, Current Leases peaked at $1.2 million in Q1 2026 and troughed at $39000.0 in Q1 2023.
- A 5-year average of $427000.0 and a median of $300000.0 in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2023 and 2024: Current Leases sank 87.0% in 2023, then jumped 669.23% in 2024.
- A 5-year view of Current Leases shows it stood at $200000.0 in 2022, then soared by 50.0% to $300000.0 in 2023, then surged by 66.67% to $500000.0 in 2024, then jumped by 45.2% to $726000.0 in 2025, then soared by 60.19% to $1.2 million in 2026.
- Business Quant data shows SLNO's Current Leases at $1.2 million in Q1 2026, $726000.0 in Q4 2025, and $700000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 726,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 676,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 448,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 256,000.00 |
| Jun 30, 2023 | 212,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 239,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 300,000.00 |
| Jun 30, 2021 | 180,000.00 |